What is the long-term trend for Clorox's international — income (loss) from equity method investments?

Over 3 years (2022 to 2025), Clorox's international — income (loss) from equity method investments has grown at a -12.6% compound annual growth rate (CAGR), from $6M to $4M.

Clorox (CLX) International — Income (Loss) from Equity Method Investments

Screener

Other segment segments

Health and Wellness

$0—

Household

$0—

Lifestyle

$0—

Similar metrics at other companies

TRUInternational — Income (Loss) from Equity Method Investments

$400K-90.7%

SBUXInternational — Income (Loss) from Equity Method Investments

$22.8M+1,854%

UGIUGI International — Income (Loss) from Equity Method Investments

$0—

SGITempur Sealy International — Income (Loss) from Equity Method Investments

$5.1M+6.3%

TDS

TDSArray — Income (Loss) from Equity Method Investments

$40.41M+12.5%

GMGMI — Income (Loss) from Equity Method Investments

$82M+6.5%

Other financials

Income statement

See full

Revenue$1.7B+0.1%

Gross profit$722.0M-3.0%

Net income$187.0M+0.5%

EPS (diluted)$1.54+2.7%

Balance sheet

See full

Cash & equivalents$1.2B+418%

Total debt$4.5B+52.4%

Total equity-$67.0M-348%

Total assets$6.4B+16.8%

Cash flow

See full

Operating cash flow$311.0M+72.8%

CapEx$43.0M-18.9%

Free cash flow$269.0M+112%

Valuation

See full

Market cap$12.8B-17.3%

Enterprise value$16.1B-11.6%

P/E16.9×-2.2×

P/S1.9×-0.3×

Profitability

See full

Gross margin43.8%-1.4pp

Net margin11.2%+1.3pp

FCF margin11.5%+1.8pp

Returns & leverage

See full

Return on equity249.6%+147pp

Debt / equity9.1×+0.1×

Current ratio0.8×+0.1×

Where this comes from

Reported directly by Clorox in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The source filing: Clorox’s 10-Q, filed April 30, 2026.

Filed: Apr 30, 2026, 4:48 PM EDT
Fiscal quarter: Q3 FY2026
Calendar quarter: Q1 2026
Accession: 0000021076-26-000019

Line item	Health and Wellness	Household	Lifestyle	International	Corporate and Other	Total Company
Balance as of 3/31/2026	$1,198	$1,085	$1,098	$1,306	$1,749	$6,436
Balance as of 6/30/2025	1,217	1,091	1,103	1,329	821	5,561
(Income) Loss from equity investees included in Other (income) expense, net
Three months ended 03/31/2026	—	—	—	—	—	—
Three months ended 03/31/2025	—	—	—	—	—	—
Nine months ended 03/31/2026	—	—	—	(2)	—	(2)
Nine months ended 03/31/2025	—	—	—	(3)	—	(3)
Capital expenditures

Item 1. Financial Statements

FAQ

What is Clorox's international — income (loss) from equity method investments?: Clorox (CLX) reported international — income (loss) from equity method investments of $0 in Q1 2026.
What is the long-term trend for Clorox's international — income (loss) from equity method investments?: Over 3 years (2022 to 2025), Clorox's international — income (loss) from equity method investments has grown at a -12.6% compound annual growth rate (CAGR), from $6M to $4M.
What does international — income (loss) from equity method investments mean?: Reflects the company's share of the net income or loss from entities in which it holds a significant influence but not full control within the international segment. This highlights the performance of joint ventures or strategic partnerships.